Drug Profile
Secretin - ChiRhoClin
Alternative Names: ChiRhoStim; Synthetic secretin diagnostics - ChiRhoClinLatest Information Update: 24 Sep 2021
Price :
$50
*
At a glance
- Originator ChiRhoClin
- Class Antipsychotics; Behavioural disorder therapies; Gastrointestinal hormones; Neuropeptides; Peptide diagnostics; Peptide hormones
- Mechanism of Action Gastrointestinal hormone replacements; Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Exocrine pancreatic insufficiency; Pancreatic cancer
- No development reported Pain; Pancreatitis
Most Recent Events
- 12 Apr 2021 No development reported - Phase-II for Pancreatitis in USA (IV) (NCT03686618)
- 01 Oct 2018 Phase-II clinical trials in Pancreatitis in USA (IV) (NCT03686618)
- 27 Sep 2018 ChiRhoClin plans the phase II SNAP trial for acute Pancreatitis in the US (IV) (NCT03686618)